Prof. Dr. med. Georg Schett

Lehrstuhl für Innere Medizin III

Comparison of physician and artificial intelligence-based symptom checker diagnostic accuracy (2022) Gräf M, Knitza J, Leipe J, Krusche M, Welcker M, Kuhn S, Mucke J, et al. Journal article Re-exposure with a TNF inhibitor bio-similar was well tolerated and led to sustained control of psoriatic arthritis after allergic reaction to the TNF inhibitor bio-originator (2022) Valor-Mendez L, Dorn C, Manger B, Schett G, Kleyer A Journal article, Letter Inflammatory activation of the FcγR and IFNγR pathways co-influences the differentiation and activity of osteoclasts (2022) Grötsch B, Schachtschabel E, Tripal P, Schmid B, Smith AS, Schett G, Bozec A Journal article Propionate induced bacterial-derived histamine promotes resolution of synovial inflammation (2022) Dürholz K, Lucas S, Schmid E, Schaelter F, Frech M, Azizov V, Hofmann J, et al. Conference contribution The role of joint-draining lymph node stromal cells in inflammatory arthritis (2022) Schälter F, Azizov V, Frech M, Dürholz K, Sokolova M, Hendel A, Focke K, et al. Conference contribution Microbiota-derived propionate modulates megakaryopoiesis and platelet function (2022) Schmid E, Dürholz K, Frech M, Otterbein N, Lucas S, Rauh M, Schett G, et al. Conference contribution Abatacept Significantly Reduces Subclinical Inflammation During Treatment (6 Months), This Persists After Discontinuation (12 Months), Resulting in a Delay in the Clinical Development of RA in Patients at Risk of RA (The ARIAA Study) (2022) Rech J, Kleyer A, Ostergaard M, Hagen M, Mendez LV, Tascilar K, Krönke G, et al. Conference contribution How Well Does Ultrasound-assessed Synovitis in Reduced Joint Sets Predict the Response to Secukinumab in Patients with Active Psoriatic Arthritis and Inadequate Response to Conventional DMARDs? - Exploratory Results from a Phase 3b Study (2022) D'Agostino MA, Conaghan PG, Gaillez C, Naredo E, Mandl P, Carron P, Senolt L, et al. Conference contribution A Symptom Checker App Is Better at Classifying Inflammatory Disease Than Physicians Who Are Presented Identical Information (2022) Gräf M, Knitza J, Leipe J, Krusche M, Welcker M, Kuhn S, Mucke J, et al. Conference contribution Changes in Serum Cytokines by Week 24 Correlate with Long-Term Efficacy of Guselkumab Through Two Years in Bio-Naive Adults with PsA (2022) Siebert S, Schett G, Raychaudhuri SP, Guma M, Chen W, Gao S, Chakravarty S, et al. Conference contribution